ArticleScientific reports2026
Probiotics regulate the intestinal microbiome to promote growth in juvenile Salmo trutta fario.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Probiotics improve aquaculture growth and immunity, but their dosage effects on gut microbes remain unclear. This study evaluated the impact of different levels of Effective Microorganisms (EM) probiotics on growth performance and intestinal microbiota of Juvenile Salmo trutta fario. Dietary EM supplementation significantly enhanced growth, with the medium-dose group (0.5% EM) exhibiting the best performance. Dietary EM supplementation significantly enhanced growth, with the medium-dose group (0.5% EM) showing the best performance. EM influenced hepatic antioxidants, with the medium-dose group similar to the control, and altered serum biochemistry, particularly in medium and high-dose groups, while most hematological parameters remained unchanged. Furthermore, 0.5% EM reduced beta diversity and inter-individual variation in the gut microbiota, suggesting enhanced microbial stability. EM supplementation altered the relative abundance of beneficial genera, such as Lactobacillus, Bifidobacterium, and Faecalibacterium, in a dose-dependent manner. Co-occurrence network analysis revealed several probiotic genera as potential keystone taxa, suggesting their crucial roles in maintaining the stability and function of the intestinal microbiota. Overall, EM exhibited clear benefits for growth and development, with 0.5% showing superior effects over 0.1% and 1%, emphasizing the importance of probiotic dosage for fish health and providing a basis for optimizing EM application in Salmo trutta aquaculture.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.